The PSA has allowed us to detect cancer at an earlier stage, and it has reduced the number of men with widespread metastasis from 40 per cent to less than five per cent. Too much ink and angst have been spilled in debating whether the PSA blood test should be used to screen for prostate cancer. Read the article.
Checking PSA is not stepping onto a slippery slope to inevitable biopsies Read More »
September 2019 Awareness Night Prostate Cancer and the Genes You Are Born With Dr. Neil Fleshner, MD, MPH, FRCSC Chair & Professor, University of Toronto Department of Urology Head,Division of Urology University Health Network (incorporating Princess Margaret Cancer Centre) CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 39:59 minutes <
Video: “Prostate Cancer and the Genes You Are Born With” Read More »
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, according to research by Queen Mary University of London. Read the article.
New blood test for prostate cancer is highly-accurate and avoids invasive biopsies Read More »
Cochrane reviews are structured, systematic, focused reviews of evidence in the field of medicine that either support or do not support specific forms of diagnosis and management of patients with or suspected of having particular disorders. A newly published Cochrane review by Drost et al. has addressed the topic of “Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer“, and had just been published by the Cochrane Library.
MRI and MRI-guided biopsies — a new Cochrane review Read More »
March 2019 Awareness Night Prostate Cancer Genetics: Where are we now? Justin Lorentz MSc, CGC Cancer Genetic Counsellor Lead,Male Oncology Research and Education (MORE) Dept of Radiation Oncology, Sunnybrook Odette Cancer Centre CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 41:24 minutes
Video: “Prostate Cancer Genetics: Where are we now?” Read More »
All men should be screened for prostate cancer, at some point, but those who are most at risk for the condition might no longer need a biopsy and surgery under brand new guidelines from the National Institutes of Health and Care Excellence. Read the article here.
Todd Morgan shares the unique program that he and his GU team at the University of Michigan have implemented in an effort to gain a better understanding of the genetics and genomics involved with progression in prostate cancer. Watch the video here.
Genetic Screening for Patients with Prostate Cancer Read More »
Prostate Cancer Canada is encouraging men to get tested for the potentially deadly disease with a bold campaign that references historical and fictional characters in the form of latex gloves – yes, those donned by doctors for the often dreaded digital rectal exam meant to detect the presence of tumours in the male sex gland. Read the article here.
Cancer remains one of the world’s top healthcare challenges, but over the years our ability to treat the disease has dramatically improved. In fact, there is a sense that a new generation of therapies – and particularly those harnessing the power of the immune system – could dramatically extend expected survival and even effect long-term cures in patients. Read the article here.
Cancer immunotherapy: What’s on the horizon? Read More »
Prostvac-V/F, an investigational prostate cancer vaccine regimen, does not improve overall survival among men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer, according to the findings of the phase 3 PROSPECT trial. Read the article here.
Prostate Cancer Vaccine Found Not To Improve Survival Read More »